From December 27, 2023 to March 31, 2024, the company has repurchased 3,505,808 shares, representing 0.18% for CNY 15.59 million. With this, the company has completed the repurchase of 3,505,808 shares, representing 0.18% for CNY 15.59 million under the buyback announced on December 28, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.63 CNY | -0.22% | +1.09% | -0.64% |
05-28 | Huapont Life Sciences Co.,Ltd Implements Final Cash Dividend for 2023, Payable on June 03, 2024 | CI |
05-24 | Huapont Life Sciences Co.,Ltd Approves Cash Dividend for 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-0.64% | 1.26B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 002004 Stock
- News Huapont Life Sciences Co.,Ltd
- Tranche Update on Huapont Life Sciences Co.,Ltd's Equity Buyback Plan announced on December 28, 2023.